Glaucoma
Conditions
Interventions
Experimental group:-Combined Phacoemulsification-Endoscopic Cyclophotocoagulation(Phaco-ECP) -Phacoemulsification, for two years
Control group:Phaco-ECP, Phacoemulsification to remove the cataratous lens and insertion of an intraocular lens and endoscopic cyclophotocoagulation to ablate the ciliary processes to reduce aqueous p
Sponsors
Department of Ophthalmology and Visual Sciences, the Chinese University of Hong Kong
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. A diagnosis of PACG; 2. Requiring 2 or more IOP-lowering drugs to control IOP, or IOP >21mmHg on maximally tolerable drugs; 3. Able and willing to give informed consent, prior to randomization; 4. Older than 18 years of age.
Exclusion criteria
Exclusion criteria: 1. Previous intraocular surgery or cyclophotocoagulation, with the exception of laser peripheral iridotomy and argon laser peripheral iridoplasty; 2. Secondary causes of angle closure including iridocorneal-endothelial syndrome, neovascular glaucoma etc.; 3. Unable to cooperate for reliable visual field and OCT examination.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome measures are IOP and the number of IOP-lowering drugs.; | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcome measures include BCVA, surgical complications, and need for additional surgical interventions.; | — |
Countries
China
Contacts
Public ContactProf. Tham Chee Yung Clement
Hong Kong Eye Hospital
Outcome results
None listed